|
C1D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.07260000051335E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.92790000034194E-07 |
| Normal-vs-Stage2 |
2.618200E-04 |
| Normal-vs-Stage3 |
8.820900E-04 |
| Normal-vs-Stage4 |
1.037760E-01 |
| Stage1-vs-Stage2 |
8.482400E-01 |
| Stage1-vs-Stage3 |
3.701000E-01 |
| Stage1-vs-Stage4 |
2.116000E-01 |
| Stage2-vs-Stage3 |
5.841600E-01 |
| Stage2-vs-Stage4 |
3.419600E-01 |
| Stage3-vs-Stage4 |
5.410800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.27700000018827E-07 |
| Normal-vs-AfricanAmerican |
8.03249999999922E-05 |
| Normal-vs-Asian |
8.447200E-01 |
| Caucasian-vs-AfricanAmerican |
5.574800E-01 |
| Caucasian-vs-Asian |
2.553200E-01 |
| AfricanAmerican-vs-Asian |
1.095240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.03929984010642E-10 |
| Normal-vs-Female |
1.707580E-02 |
| Male-vs-Female |
6.160000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.811700E-04 |
| Normal-vs-Extreme_Weight |
3.73360009575663E-10 |
| Normal-vs-Obese |
4.380500E-04 |
| Normal-vs-Extreme_Obese |
9.561500E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.118000E-01 |
| Normal_Weight-vs-Obese |
9.858600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.763400E-01 |
| Extreme_Weight-vs-Obese |
7.822500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.713400E-01 |
| Obese-vs-Extreme_Obese |
8.834600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.150100E-02 |
| Normal-vs-Age(41-60Yrs) |
7.69660000177197E-08 |
| Normal-vs-Age(61-80Yrs) |
3.05359999996924E-06 |
| Normal-vs-Age(81-100Yrs) |
2.404500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.934000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.515840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.518620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.588000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.684600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.616600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.01340000227646E-08 |
| Normal-VS-Type2 PRCC |
1.186870E-04 |
| Normal-VS-KIRP CIMP |
7.583800E-01 |
| Normal-VS-Unclassified PRCC |
5.60160000051546E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.621400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.269840E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.689600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.278200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.174440E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.115500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.90090000021337E-07 |
| Normal-vs-N1 |
4.882000E-02 |
| Normal-vs-N2 |
6.960000E-03 |
| N0-vs-N1 |
4.141600E-02 |
| N0-vs-N2 |
6.751200E-01 |
| N1-vs-N2 |
2.671800E-01 |
|
|
